Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (20207)	3/31/1999 6:15:00 PM
From: DaiS	Respond to of 23519

Vlad, I thought this was interesting too. <Other pending patent applications focus on prevention and/or treatment of conditions other than sexual dysfunction, including vascular disorders such as peripheral vascular disease ("PVD"). > The K channel gene therapy work could be relevant to PVD I think. I am trying to find out about the reference to gene therapy in relation to caner! This puzzling. They are busy bees at Vivus with all these patent applications. That is how they spend their time. DaiS